Abstract
The treatment of young adults (16 to 39 years of age) with acute lymphocytic leukemia (ALL) has been a focus of clinical research over the past decade. This review will focus on the biology, optimal treatment, treatment-related toxicities, and psychosocial issues in this patient population.
Publication types
-
Research Support, Non-U.S. Gov't
-
Review
MeSH terms
-
Adolescent
-
Adult
-
Antineoplastic Combined Chemotherapy Protocols / adverse effects
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use
-
Chromosome Aberrations
-
Gene Expression Regulation, Leukemic
-
Hematopoietic Stem Cell Transplantation
-
Humans
-
Patient Compliance
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / etiology*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / psychology*
-
Precursor Cell Lymphoblastic Leukemia-Lymphoma / therapy*
-
Transplantation, Homologous
-
Young Adult